Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00827736
Other study ID # 00.058
Secondary ID
Status Completed
Phase Phase 4
First received January 20, 2009
Last updated January 22, 2009
Start date June 2002
Est. completion date March 2006

Study information

Verified date January 2009
Source Onze Lieve Vrouwe Gasthuis
Contact n/a
Is FDA regulated No
Health authority Netherlands: The Central Committee on Research Involving Human Subjects (CCMO)
Study type Interventional

Clinical Trial Summary

The standard treatment of anal fissure in the netherlands (ISDN ointment) is being compared to a relatively new treatment (injection of Botox in the internal anal sphincter). The study hypothesis is that after 4 months, Botox has healed more patients than ISDN. The comparison is done blinded for the surgeon and the patient.


Recruitment information / eligibility

Status Completed
Enrollment 73
Est. completion date March 2006
Est. primary completion date March 2006
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- all consecutive patients over the age of 18 with a chronic anal fissure presenting to our surgical outpatient clinic

Exclusion Criteria:

- pregnancy

- previous anal surgery

- Crohn's disease

- systemic causes of an anal fissure

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Procedure:
Botox
injection of 10U of BT (Botox®; Allergan, Irvine, California, USA) in the IAS on each side of the anterior midline.
Drug:
ISDN ointment
application of ISDN 1% ointment 6 times a day
Placebo
Injection of placebo into internal anal sphincter (ISDN ointment arm) Applied to the anoderm six times a day (Botox injection arm)

Locations

Country Name City State
Netherlands Onze Lieve Vrouwe Gasthuis Amsterdam Noord Holland

Sponsors (1)

Lead Sponsor Collaborator
Onze Lieve Vrouwe Gasthuis

Country where clinical trial is conducted

Netherlands, 

References & Publications (1)

Brisinda G, Maria G, Bentivoglio AR, Cassetta E, Gui D, Albanese A. A comparison of injections of botulinum toxin and topical nitroglycerin ointment for the treatment of chronic anal fissure. N Engl J Med. 1999 Jul 8;341(2):65-9. Erratum in: N Engl J Med — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary macroscopic healing of the fissure 4 months No
Secondary complications 12 months Yes
Secondary fissure recurrence 12 months No
Secondary fissure related pain 12 months No
Secondary costs 12 months No
See also
  Status Clinical Trial Phase
Completed NCT06216223 - Laser Versus Surgery in Anal Diseases in Inflammatory Bowel Patients N/A
Not yet recruiting NCT05405634 - Microbiota in Chronic Anal Fissure and Its Association With Prognosis
Completed NCT05736926 - Anal Fissure Among Survivors of COVID-19 Virus Infection.
Enrolling by invitation NCT00980369 - The Importance of Lateral Internal Sphincterotomy Incision: Parallel or Vertical N/A
Completed NCT05616455 - Efficacy and Safety of Propionibacterium Extract Gel Versus 0.4% Glyceryl Trinitrate Ointment in the Treatment of Chronic Anal Fissure: a Randomised Controlled Trial Phase 4
Completed NCT04173130 - Monocentric Feasibility Study for a New Medical Device for the Treatment of Anal Fissure With Botulinum Toxin N/A
Completed NCT03345511 - Ultrasound Guided Caudal Block for Benign Anal Surgery N/A
Completed NCT05341180 - Efficacy of Polyethylene Glycol vs Lactulose With Isabgol in Acute Fissure-in-Ano: PEGASIS Trial Phase 2/Phase 3
Completed NCT03528772 - Topical Minoxidil Versus Topical Glyceryl Trinitrate in Treatment of Chronic Anal Fissure N/A
Active, not recruiting NCT04428697 - Sungurtekin Technique vs. Closed Lateral Internal Sphincterotomy Technique N/A
Terminated NCT02023047 - An Open Label Multi-Dose Study to Examine the Effect of Coated Nifedipine Suppository on Anal Fissure Pain and Healing Phase 1/Phase 2
Withdrawn NCT01920074 - Pharmacokinetic,Safety and Exploratory Efficacy of RECTIV® in Adolescents With Chronic Anal Fissure Phase 4
Recruiting NCT01039051 - Diet and Lifestyle Intervention Study in Postpartum Women in China Phase 2/Phase 3
Completed NCT00210444 - Efficacy Study of Dysport® in the Treatment of Anal Fissure. Phase 2
Withdrawn NCT02667535 - PK, PD and Safety Comparative Trial of Isosorbide Mononitrate Gel in Healthy Participants and With Anal Fissure Phase 1
Not yet recruiting NCT06049524 - Could Preoperative Assessment of Physical and Psychological Status Help Predict Pain After Anorectal Surgery?
Not yet recruiting NCT05709717 - Regenerative Therapy With Autologous Stromal Vascular Fraction Derived Mesenchymal Stem Cells and Platelet-rich Plasma to Treat Complex Perianal Diseases
Completed NCT05038605 - Topical vs Oral Metronidazole After Benign Anorectal Surgery N/A
Not yet recruiting NCT03780998 - Effects of Sodium Pentaborat Based Gel on Perianal Benign Diseases
Completed NCT03426449 - Posterolateral Versus Lateral Internal Anal Sphincterotomy for Chronic Anal Fissure N/A